期刊文献+

血清生长抑制蛋白家族成员5水平与早期胃癌患者内镜黏膜下剥离术后复发的关系

Relationship between serum ING5 levels and recurrence after endoscopic submucosal dissection in early gastric cancer patients
在线阅读 下载PDF
导出
摘要 目的探讨血清生长抑制蛋白家族成员5(ING5)表达水平与早期胃癌患者内镜黏膜下剥离术(ESD)后复发的关系。方法选取2017年5月-2019年5月于该院行ESD的早期胃癌患者96例(研究组),另选择同期该院健康体检者96例(对照组)。采用实时荧光定量聚合酶链反应(qRT-PCR)检测ING5表达水平。通过多因素Logistic回归模型,分析影响早期胃癌患者ESD术后复发的因素。结果研究组血清ING5表达水平明显低于对照组,差异有统计学意义(P<0.05);血清ING5表达水平与分化程度和浸润深度有关(P<0.05);早期胃癌患者ESD术后,复发组癌组织为中分化和浸润深度为黏膜下层比例明显高于未复发组(P<0.05);ING5<0.75、分化程度为中分化和浸润深度为黏膜下层,是影响早期胃癌患者ESD术后复发的独立危险因素(P<0.05)。结论ING5在早期胃癌患者的血清中呈低表达,而且是ESD术后复发的影响因素之一,其可作为一种抑癌基因标志物应用于临床研究中。 Objective To explore the relationship between serum inhibitor of growth family member 5(ING5)expression levels and postoperative recurrence after endoscopic submucosal dissection(ESD)in early gastric cancer patients.Methods 96 patients of early gastric cancer(study group)who underwent ESD surgery from May 2017 to May 2019,while 96 healthy patients individuals who underwent physical examinations during the same period(control group).Real time fluorescent quantitative polymerase chain reaction(qRT-PCR)was used to detect the ING5 expression level.Analysis of influencing factors through multivariate Logistic regression.Results The serum ING5 expression level in the study group was significantly lower than that in the control group(P<0.05);The serum ING5 expression level was related to the degree of differentiation and depth of infiltration(P<0.05);The proportion of moderate differentiation and submucosal infiltration depth in gastric cancer tissue in the recurrent group of gastric cancer patients after ESD surgery was significantly higher than those in the non recurrent group(P<0.05);ING5<0.75,moderate differentiation and submucosal infiltration depth were independent risk factors for postoperative recurrence in early gastric cancer patients undergoing ESD surgery(P<0.05).Conclusion The expression of ING5 is down-regulated in the serum of patients with early gastric cancer,and is an influencing factor of postoperative recurrence of ESD.It can be used as a tumor suppressor gene marker in clinical research.
作者 李国东 Li Guodong(Department of Gastroenterology,Baoding No.1 Central Hospital,Baoding,Hebei 071000,China)
出处 《中国内镜杂志》 2025年第2期70-75,共6页 China Journal of Endoscopy
关键词 早期胃癌 生长抑制蛋白家族成员5(ING5) 分化程度 浸润深度 内镜黏膜下剥离术(ESD) early gastric cancer inhibitor of growth family member 5(ING5) degree of differentiation invasion depth endoscopic submucosal dissection(ESD)
  • 相关文献

参考文献14

二级参考文献109

  • 1无.胃癌规范化诊疗指南(试行)[J].中国医学前沿杂志(电子版),2013,5(8):56-63. 被引量:371
  • 2Yao-Chi Liu,Chen-Yang Shen,Hurng-Sheng Wu,Tsai-Yuan Hsieh,De-Chuan Chan,Cheng-Jueng Chen,Jyh-Cherng Yu,Cheng-Ping Yu,Horng-Jyh Harn,Peng-Jen Chen,Chung-Bao Hsieh,Teng-Wei Chen,Huan-Mieng Hsu.Mechanisms inactivating the gene for E-cadherin in sporadic gastric carcinomas[J].World Journal of Gastroenterology,2006,12(14):2168-2173. 被引量:17
  • 3Ajani JA,Bekaii-Saab T,Yang G. NCCN clinical practice guidelines in oncology:gastric cancer[M].2009.
  • 4Karam SM. Cellular origin of gastric cancer[J].Ann N Y Aced Sci,2008.162-168.
  • 5Hamashima C,Shibuya D,Yamazaki H. The Japaneseguidelines for gastric cancer screening[J].Jpn 1 Clin Oncol,2008,(04):259-267.
  • 6Leung WK,Wu MS,Kakugawa Y. Asia Pacific WorkingGroup on Gastric Cancer.Screening for gastric cancer in Asia:current evidence and practice[J].{H}LANCET ONCOLOGY,2008,(03):279-287.
  • 7Jatzko GR,Lisborg PH,Denk H. A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan[J].{H}CANCER,1995,(08):1302-1312.
  • 8Parkin DM,Bray F,Ferlay J. Global cancer statistics,2002[J].{H}CA-A Cancer Journal for Clinicians,2005,(02):74-108.
  • 9Sierra A,Regueira FM,Hernlxndez-LiwGin JL. Role of the extended lymphadenectomy in gastric cancer surgery:experience in a single institution[J].{H}ANNALS OF SURGICAL ONCOLOGY,2003,(03):219-226.
  • 10董志伟;谷铣之.临床肿瘤学[M]{H}北京:人民卫生出版社,20029-27.

共引文献569

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部